Back to search
FDAFDA · Food and drugs·Recall number D-0290-2021

Famotidine Tablets USP 40mg, 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India, NDC 65862-860-99

Published March 10, 2021 · Recall initiated: January 20, 2021

Summary

FDA records drug Class II recall D-0290-2021, published March 10, 2021 and initiated January 20, 2021. Recalling firm: Aurobindo Pharma USA Inc.; Status: Terminated; Reported quantity: 1296 bottles; Lot: Lot #: P2000467, Exp 7/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of foreign tablets/capsules: Famotidine 20mg and ibuprofen 400mg tablets were found in a lot of famotidine 40mg.

What to do

Voluntary: Firm initiated · Letter

Get an email if FAMOTIDINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FAMOTIDINE
Manufacturer
Aurobindo Pharma USA Inc.
Distributor
TX, CA, GA, PA
Lot
Lot #: P2000467, Exp 7/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Famotidine Tablets USP 40mg, 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India, NDC 65862-860-99 recalled?

Yes. FDA published recall D-0290-2021 on March 10, 2021. Reported hazard: Presence of foreign tablets/capsules: Famotidine 20mg and ibuprofen 400mg tablets were found in a lot of famotidine 40mg.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FAMOTIDINE.